Research location

Stoke-on-Trent

Staffordshire, United Kingdom

Published trials33

Site observations33

Linked trials published33

Page1 / 1

Research activity in Stoke-on-Trent

Staffordshire, United Kingdom

CureCurrent currently publishes aggregate city-level research activity for this location: 33 trials and 33 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Stoke-on-Trent

33 linked trials · page 1 of 1

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)NCT07218146 · 2025-11-30 · 1 site observation

NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) PathwayNCT06672926 · 2025-09-23 · 1 site observation

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung CancerNCT06712355 · 2025-02-03 · 1 site observation

Shortened High-dose Palliative Radiotherapy for Lung CancerNCT06483308 · 2024-11-27 · 1 site observation

ACTIVE_NOT_RECRUITING

Performance and Adherence in Children Using SpacersNCT05366309 · 2022-09-01 · 1 site observation

ACTIVE_NOT_RECRUITING

Real-world Dapagliflozin Experience in Patients With Heart Failure in United Kingdom.NCT05188144 · 2021-11-29 · 1 site observation

Is Fat in the Liver a Marker of Post-Pregnancy Glycaemic Deterioration in Women With Gestational Diabetes?NCT04362540 · 2019-05-05 · 1 site observation

ACTIVE_NOT_RECRUITING

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)NCT03834506 · 2019-05-02 · 1 site observation

Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)NCT03834519 · 2019-05-02 · 1 site observation

Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02NCT03426345 · 2018-02-16 · 1 site observation

A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04NCT03383146 · 2018-02-01 · 1 site observation

Foot Assessment in People With Diabetes: A Quantitative Diagnostic ApproachNCT03089463 · 2017-11-27 · 1 site observation

Tissue Engineering Approaches to Treat COPDNCT04878445 · 2017-08-31 · 1 site observation

ACTIVE_NOT_RECRUITING

Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)NCT03142334 · 2017-06-09 · 1 site observation

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)NCT03040999 · 2017-04-05 · 1 site observation

International Breast Cancer Biomarker,Standard of Care and Real World Outcomes StudyNCT03078036 · 2017-03-13 · 1 site observation

Stem Cell Strategies for the Treatment of Chronic AsthmaNCT04883320 · 2016-08-31 · 1 site observation

ACTIVE_NOT_RECRUITING

Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot StudyNCT02939456 · 2016-06-01 · 1 site observation

Avelumab in First-line NSCLC (JAVELIN Lung 100)NCT02576574 · 2015-10-29 · 1 site observation

Virtual Environment Radiotherapy to Improve Patients' Compliance to Radiotherapy (RT) in Prostate CancerNCT03326440 · 2015-10-08 · 1 site observation

Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate CancerNCT02200614 · 2014-09-12 · 1 site observation

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.NCT02075541 · 2014-07-08 · 1 site observation

IMproved PRegnancy Outcome by Early DetectionNCT01891240 · 2013-11-01 · 1 site observation

Validation of Structured Light Plethysmography: AsthmaNCT02543333 · 2013-07-01 · 1 site observation

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation

A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different TreatmentsNCT01529112 · 2011-11-01 · 1 site observation

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple SclerosisNCT01201356 · 2010-09-13 · 1 site observation

ATX-MS-1467 in Patients With Relapsing Forms of Multiple SclerosisNCT01097668 · 2010-03-01 · 1 site observation

Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the BreastNCT00470236 · 2007-06-01 · 1 site observation

A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson'sNCT00331149 · 2006-06-20 · 1 site observation

Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir HypersensitivityNCT00340080 · 2006-04-01 · 1 site observation

Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyNCT00268476 · 2005-07-08 · 1 site observation

ACTIVE_NOT_RECRUITING

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskNCT00056407 · 2003-03-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.